Ulcerated infantile hemangioma

Authors

  • Nídia Belo Pediatrics Department, Hospital do Espírito Santo de Évora
  • Patrícia Maio Pediatrics Department, Hospital do Espírito Santo de Évora
  • Susana Gomes Pediatrics Department, Hospital do Espírito Santo de Évora
  • Carla Cruz Pediatrics Department, Hospital do Espírito Santo de Évora
  • Maria João P. Lopes Dermatology Department, Centro Hospitalar Lisboa Central

DOI:

https://doi.org/10.25753/BirthGrowthMJ.v28.i1.13781

Keywords:

infantile hemangioma, propranolol, ulceration

Abstract

Infantile hemangiomas are the most frequent vascular tumors in pediatric age. Diagnostic can be challenging due to variable clinical presentation and natural history. Most cases have a favorable evolution. Treatment may be required according to tumor location, extension, and complications. Propranolol is an effective and safe treatment.
The case of an infant with perianal ulcerated hemangiomas treated with propranolol with clinical improvement is reported.

Downloads

References

Ravenscroft J. Management of Infantile Haemangioma. Paediatrics and Child Health. 2014. 25:2.

Della Nina BI, Oliveira ZN, Machado MC, Macea JM. Apresentação, evolução e tratamento dos hemangiomas cutâneos - experiência do Ambulatório de Dermatologia Infantil do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. An Bras Dermatol. 2006;81(4):323-7.

Gontijo B, Silva CMR, Pereira LB. Hemangioma da Infancia. An Bras Dermatol. 2003;78(6):651-673.

A. Lanoel A, Tosi V, Bocian M, Lubieniecki F, Poblete SB, García HO, et al. Úlceras perianales sobre hemangioma con crecimiento mínimo o detenido segmentário. Actas Dermosifiliogr. 2012;103(9):820-3

Bonini FK, Bellodi FS, Souza EM. Hemangioma infantil tratado com propranolol. An Bras Dermatol. 20011;86(4):763-6

Hiraki PY, Goldenberg DC. Diagnóstico e tratamento do hemangioma infantil. Rev. Bras. Cir. Plást. 2010; 25(2): 388-97

Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, et al. Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference. Pediatrics. 2013. 131(1):128- 140

Lawley LP. Siegfried E, Todd JL. Propranolol Treatment for Hemangioma of Infancy: Risks and Recomendations. Pediatric Dermatology. 2009. 26(5): 610-4.

Melo IS, Gonçalves V, Anjos R. Propranolol nos hemangiomas infantis: casuística nacional com 30 doentes. Acta Pediatr Port 2012;43(5):190-4

Shah SD, Baselga E, McCuaig C, Pope E, Coulie J, Boon LM. Rebound growth of Infantile Hemangiomas After Propranolol Therapy. Pediatrics. 2016. 137(4): 1-8

Downloads

Published

2019-04-11

How to Cite

1.
Belo N, Maio P, Gomes S, Cruz C, Lopes MJP. Ulcerated infantile hemangioma. REVNEC [Internet]. 2019Apr.11 [cited 2025May14];28(1):18-21. Available from: https://revistas.rcaap.pt/nascercrescer/article/view/13781

Issue

Vol. 28 No. 1 (2019)

Section

Case Reports

License

Copyright and Authors' Rights

All articles published in Nascer e Crescer - Birth and Growth Medical Journal are Open Access and comply with the requirements of funding agencies or academic institutions. For use by third parties, Nascer e Crescer - Birth and Growth Medical Journal adheres to the terms of the Creative Commons License "Attribution - Non-Commercial Use (CC-BY-NC)".

It is the author's responsibility to obtain permission to reproduce figures, tables, etc. from other publications.

Authors must submit a Conflict of Interest statement and an Authorship Form with the submission of the article. An e-mail will be sent to the corresponding author confirming receipt of the manuscript.

Authors are permitted to make their articles available in repositories at their home institutions, provided that they always indicate where the articles were published and adhere to the terms of the Creative Commons license.

Most read articles by the same author(s)